MedPath

MANCONI MAURO

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

A Proof of Concept, Phase 2, Double-blind, Randomized Trial With d-Methadone Product Versus Placebo

Phase 2
Recruiting
Conditions
Restless Legs Syndrome
Interventions
Other: Placebo
First Posted Date
2019-10-30
Last Posted Date
2024-03-01
Lead Sponsor
Mauro Manconi
Target Recruit Count
50
Registration Number
NCT04145674
Locations
🇮🇹

Sleep Center, IRCCS San Raffaele, Milan, Italy

🇨🇭

Schlaf-Wach-Epilepsie Zentrum, Inselspital, Bern, Switzerland

🇨🇭

Neurologie / Schlaflabor Kantonsspital Graubünden, Chur, Switzerland

and more 1 locations

Efficacy of a Novel MAD in OSA

Not Applicable
Completed
Conditions
OSA
Obstructive Sleep Apnea
Apnea, Obstructive
Obstructive Sleep Apnea Syndrome
Sleep Apnea, Obstructive
OSAH
Interventions
Device: Velo-Lingual Bite (BVL)
First Posted Date
2017-06-23
Last Posted Date
2019-07-01
Lead Sponsor
Mauro Manconi
Target Recruit Count
21
Registration Number
NCT03196583
Locations
🇨🇭

Sleep and Epilepsy Center, Neurocenter of Southern Switzerland, Ospedale Civico di Lugano, Ente Ospedaliero Cantonale, Lugano, TI, Switzerland

Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome

Phase 4
Completed
Conditions
Restless Legs Syndrome
Interventions
Drug: Placebo
First Posted Date
2014-01-01
Last Posted Date
2017-01-24
Lead Sponsor
Mauro Manconi
Target Recruit Count
20
Registration Number
NCT02025608
Locations
🇨🇭

Department of Neurology, Inselspital, Bern, Switzerland

🇨🇭

Neurocenter of Southern Switzerland, Lugano, Ticino, Switzerland

© Copyright 2025. All Rights Reserved by MedPath